Asset / Drug

ketamine

Drug and asset intelligence for ketamine with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 2
Stage: Development stage unavailable

Recent signals(2)

ClinicalJune 27, 2026

Study on Ketamine vs Fentanyl for Pain Management in Laparoscopic Cholecystectomy

A randomized double-blind study is comparing intraperitoneal ketamine and fentanyl as adjuvants to bupivacaine for postoperative pain control in laparoscopic cholecystectomy.

ClinicalJune 25, 2026

Study on Ketamine's Impact on Anaesthesia Depth Consistency in Laparoscopic Surgery

A randomized controlled study is set to evaluate the effect of subanaesthetic ketamine on anaesthesia depth consistency during laparoscopic surgery using automated propofol TIVA.